Omeros Corp (OMER)
3.45
+0.14
(+4.23%)
USD |
NASDAQ |
May 17, 16:00
3.445
0.00 (0.00%)
After-Hours: 20:00
Omeros Cash from Investing (Quarterly): -61.92M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -61.92M |
| December 31, 2023 | 116.24M |
| September 30, 2023 | 57.17M |
| June 30, 2023 | 35.38M |
| March 31, 2023 | -181.33M |
| December 31, 2022 | -108.49M |
| September 30, 2022 | 33.00M |
| June 30, 2022 | 24.74M |
| March 31, 2022 | -76.81M |
| December 31, 2021 | 112.42M |
| September 30, 2021 | 17.90M |
| June 30, 2021 | 30.41M |
| March 31, 2021 | 32.98M |
| December 31, 2020 | 7.996M |
| September 30, 2020 | -118.40M |
| June 30, 2020 | 32.59M |
| March 31, 2020 | 10.78M |
| December 31, 2019 | -39.24M |
| September 30, 2019 | 9.339M |
| June 30, 2019 | 15.21M |
| March 31, 2019 | 11.29M |
| December 31, 2018 | -2.361M |
| September 30, 2018 | 33.06M |
| June 30, 2018 | -14.10M |
| March 31, 2018 | 8.547M |
| Date | Value |
|---|---|
| December 31, 2017 | 5.432M |
| September 30, 2017 | -59.54M |
| June 30, 2017 | 5.846M |
| March 31, 2017 | 10.66M |
| December 31, 2016 | -6.011M |
| September 30, 2016 | -20.54M |
| June 30, 2016 | -4.416M |
| March 31, 2016 | 14.63M |
| December 31, 2015 | 7.447M |
| September 30, 2015 | 14.41M |
| June 30, 2015 | 19.62M |
| March 31, 2015 | -62.09M |
| December 31, 2014 | 14.48M |
| September 30, 2014 | 14.89M |
| June 30, 2014 | 15.70M |
| March 31, 2014 | -38.91M |
| December 31, 2013 | -4.936M |
| September 30, 2013 | 10.45M |
| June 30, 2013 | -6.312M |
| March 31, 2013 | 8.707M |
| December 31, 2012 | 8.332M |
| September 30, 2012 | -29.66M |
| June 30, 2012 | 0.742M |
| March 31, 2012 | 19.68M |
| December 31, 2011 | 7.359M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-181.33M
Minimum
Mar 2023
116.24M
Maximum
Dec 2023
-2.502M
Average
16.55M
Median
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -41.78M |
| Cash from Financing (Quarterly) | 98.43M |
| Free Cash Flow | -142.08M |
| Free Cash Flow Per Share (Quarterly) | -0.7115 |
| Free Cash Flow Yield | -66.71% |